R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma

NCT05966233 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor decision

Conditions

Diffuse Large B Cell Lymphoma Refractory
Diffuse Large B-cell Lymphoma Recurrent

Interventions

DRUG: R-DHAP
DRUG: Pola-R-DHAP

Sponsor

Fondazione Italiana Linfomi - ETS

Collaborators

[object Object]